CAS: 139262-76-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 4,4′-[1,3-Phenylenebis(oxy-4,1-phenyleneimino)]bis[4-oxo-2-Butenoic acid REF: AN-AG00A0N1CAS: 139262-76-3 | ≥98%(HPLC) | 319,00 €~3.027,00 € | Lun 29 Abr 24 |
 | H2L5186303 REF: TM-T22835CAS: 139262-76-3 | 97.23% | 52,00 €~1.606,00 € | Mar 30 Abr 24 |
 | H2L5186303 REF: 3D-PFA26276CAS: 139262-76-3 | Min. 95% | A consultar | Lun 10 Jun 24 |
![4,4′-[1,3-Phenylenebis(oxy-4,1-phenyleneimino)]bis[4-oxo-2-Butenoic acid](https://static.cymitquimica.com/products/AN/thumb/AG00A0N1.jpg)
4,4′-[1,3-Phenylenebis(oxy-4,1-phenyleneimino)]bis[4-oxo-2-Butenoic acid
CAS:139262-76-3
Fórmula:
C26H20N2O8
Pureza:
≥98%(HPLC)
Peso molecular:
488.4456
Ref: AN-AG00A0N1
| 5mg | 319,00 € | |
| 10mg | 660,00 € | |
| 25mg | 991,00 € | |
| 50mg | 1.781,00 € | |
| 100mg | 3.027,00 € |
Entrega estimada en Estados Unidos, el Lunes 29 de Abril de 2024
H2L5186303
CAS:139262-76-3
H2L5186303 is an LPA2 antagonist and can be used in studies about asthma treatment.
Fórmula:
C26H20N2O8
Pureza:
97.23%
Forma y color:
Solid
Peso molecular:
488.45
Ref: TM-T22835
| 1mg | 52,00 € | |
| 5mg | 95,00 € | |
| 10mg | 172,00 € | |
| 25mg | 369,00 € | |
| 50mg | 547,00 € | |
| 100mg | 786,00 € | |
| 500mg | 1.606,00 € | |
| 1ml*10 (DMSO) | 113,00 € |
Entrega estimada en Estados Unidos, el Martes 30 de Abril de 2024
H2L5186303
CAS:139262-76-3
H2L5186303 is a synthetic endocannabinoid that has been shown to have anticancer effects. H2L5186303 binds …
Fórmula:
C26H20N2O8
Pureza:
Min. 95%
Peso molecular:
488.45 g/mol
Ref: 3D-PFA26276
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 10 de Junio de 2024
